Chemistry & Biochemistry Colloquium – Small molecule inhibitors of the BCL6 BTB domain for diffuse large B-cell lymphoma (DLBCL) – Fengtian Xue from University of Maryland
Chemistry Room 180 3210 N. Cramer Street, MilwaukeeAbstract: Diffuse large B-cell lymphomas (DLBCLs) are life-threatening cancers that are the most common form of non-Hodgkin’s lymphomas. The current standard treatment of DLBCL involves the RCHOP regimen. However many patients treated with those therapies relapse. The transcriptional repressor BCL6... Read More